Literature DB >> 1603034

Synthesis and turnover of proteoglycans by human and bovine adult articular chondrocytes cultured in alginate beads.

H J Häuselmann1, M B Aydelotte, B L Schumacher, K E Kuettner, S H Gitelis, E J Thonar.   

Abstract

Human and bovine adult articular chondrocytes cultured in alginate beads or agarose gel retain their spherical shape and typical chondrocytic appearance for at least 5 weeks. Aggrecan is always the major population of proteoglycans (PGs) synthesized; its size varies depending upon the age of the cartilage from which the cells are derived but it is not influenced by the culture system used. Studies of human chondrocytes cultured in alginate showed that the majority of the newly-synthesized aggrecan molecules are rapidly incorporated into aggregates which can be extracted from the gel in their native form. About one-third of the aggregates formed during a 4-hour period of incubation in the presence of [35S]-sulfate are packed at high concentration in the cell-associated matrix; the remainder is present in areas of the gel further removed from the cells. Aggrecan appears to be turned over more slowly by human than by bovine cells in both culture systems; in both species, the rate of turnover is slower in alginate than in agarose. Decorin is also synthesized in small amounts but it is rapidly lost from the agarose or alginate gel.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1603034     DOI: 10.1016/s0934-8832(11)80053-3

Source DB:  PubMed          Journal:  Matrix        ISSN: 0934-8832


  52 in total

1.  Regulation of type-II collagen gene expression during human chondrocyte de-differentiation and recovery of chondrocyte-specific phenotype in culture involves Sry-type high-mobility-group box (SOX) transcription factors.

Authors:  D G Stokes; G Liu; R Dharmavaram; D Hawkins; S Piera-Velazquez; S A Jimenez
Journal:  Biochem J       Date:  2001-12-01       Impact factor: 3.857

Review 2.  Recent progress in histochemistry and cell biology.

Authors:  Stefan Hübner; Athina Efthymiadis
Journal:  Histochem Cell Biol       Date:  2012-02-25       Impact factor: 4.304

3.  Inhibition of iodine organification and regulation of follicular size in rat thyroid tissue in vitro.

Authors:  C Glaser; U Marti; M E Bürgi-Saville; C Ruchti; M Gebauer; M W Büchler; H Gerber; U Bürgi; H J Peter
Journal:  Endocrine       Date:  1999-10       Impact factor: 3.633

4.  Human chondrocyte cultures as models of cartilage-specific gene regulation.

Authors:  Mary B Goldring
Journal:  Methods Mol Med       Date:  2005

5.  In vitro comparison of six different matrix systems for the cultivation of human chondrocytes.

Authors:  Karsten Gavénis; Bernhard Schmidt-Rohlfing; Ralf Mueller-Rath; Stefan Andereya; Ulrich Schneider
Journal:  In Vitro Cell Dev Biol Anim       Date:  2006 May-Jun       Impact factor: 2.416

6.  Identification of heterogeneous cell populations in normal human intervertebral disc.

Authors:  M K Chelberg; G M Banks; D F Geiger; T R Oegema
Journal:  J Anat       Date:  1995-02       Impact factor: 2.610

Review 7.  Physical stimulation of chondrogenic cells in vitro: a review.

Authors:  Sibylle Grad; David Eglin; Mauro Alini; Martin J Stoddart
Journal:  Clin Orthop Relat Res       Date:  2011-10       Impact factor: 4.176

8.  Mechanical properties and gene expression of chondrocytes on micropatterned substrates following dedifferentiation in monolayer.

Authors:  Eric M Darling; Poston E Pritchett; Benjamin A Evans; Richard Superfine; Stefan Zauscher; Farshid Guilak
Journal:  Cell Mol Bioeng       Date:  2009-08-09       Impact factor: 2.321

9.  Keratocyte behavior in three-dimensional photopolymerizable poly(ethylene glycol) hydrogels.

Authors:  Nerea Garagorri; Sara Fermanian; Richard Thibault; Winnette McIntosh Ambrose; Oliver D Schein; Shukti Chakravarti; Jennifer Elisseeff
Journal:  Acta Biomater       Date:  2008-05-27       Impact factor: 8.947

Review 10.  Cartilage destruction by matrix degradation products.

Authors:  Tadashi Yasuda
Journal:  Mod Rheumatol       Date:  2006       Impact factor: 3.023

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.